Delivery Order SPE2DB20D3101-SPE2DB24FRJK3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5ml, a medication used for diabetes management. The contract, valued at $1,161.12, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating it was a full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $16,755.44 for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen, a major...
- This federal contract award, valued at $2,898.06, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a type of injectable medication used to treat diabetes. This delivery order has an ultimate completion date of November 9, 2023. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,322.24 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a period of performance through November 15, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with...
- This federal contract award, valued at $24,350.31, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,384.26 to AmerisourceBergen Drug Corporation, a subsidiary of Cencora, Inc. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC allows for...
- This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The award has a ceiling value of $5,495.50 and an ultimate completion date of September 26, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,944.61 Firm Fixed Price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,908.59 firm-fixed-price contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRJK3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used to manage diabetes. The contract, valued at $1,350.48, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 7, 2024. The contract is a delivery order with a firm fixed price pricing type, and it is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000, respectively, to provide a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving the military and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/6/24 |